Top
Topic: Papers from the 2nd BACR Conference "Response and Resistance in Cancer Therapy"

A special issue of Cancer Drug Resistance.

ISSN 2578-532X (Online)

Submission deadline: 30 Aug 2020

Guest Editor(s)

  • Dr. Tim Fenton
    School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK

    Website | E-mail

  • Prof. Michelle Garrett
    School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK

    Website | E-mail

  • Prof. Martin Michaelis
    School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK

    Website | E-mail

  • Dr. Mark Wass
    School of Biosciences, University of Kent, Canterbury CT2 7NJ, UK

    Website | E-mail

Special Issue Introduction

Despite substantial improvements in recent decades, the prognosis for those cancer patients who suffer from metastatic disease and depend on systemic drug therapy remains unsatisfactorily poor. Both intrinsic resistance and the formation of acquired drug resistance substantially affect the efficacy of cancer drugs. The advancement of precision therapy, in particular the development of improved methods to analyse liquid biopsies, holds promise for improved monitoring of the tumour response and the effective guidance of therapies to patients that will respond to it. The effective use of liquid biopsies will largely depend on the effective interpretation of ‘omics’ data. Moreover, functional data from pre-clinical resistance models will be needed to complement clinical data. Hence, a close and intense collaboration is required between pre-clinical researchers, clinicians, and computational biologists to develop more effective anti-cancer therapies. This conference, 2nd BACR Conference "Response and Resistance in Cancer Therapy" (https://www.bacr.org.uk/event/response-and-resistance-in-cancer-therapy), will bring together and showcase cancer researchers from these areas, who will present and discuss the latest advances in understanding the mechanisms of drug resistance in cancer, the identification of biomarkers of drug sensitivity/resistance and how they can be linked to precision medicine approaches.

Keywords

Cancer drug resistance, prognosis, systemic drug therapy, intrinsic resistance, precision medicine, tumour response, mechanism, bio-marker

Submission Deadline

30 Aug 2020

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://cdrjournal.com/pages/view/author_instructions
For Online Submission, please login at https://www.oaemesas.com/cdr
Submission Deadline: 30 Aug 2020
Contacts: Bill Li, Managing Editor , bill.li@oaepublish.com or editorial@cdrjournal.com

Published Articles

This special issue is now open for submission.